‘Targeted drug delivery system is a special form of drug delivery system where the medicament is selectively targeted or delivered only to its site of action or absorption and not to the non-target organs or tissues or cells.’
This document discusses three types of triggered drug delivery systems: bioerosion regulated, bioresponsive, and self-regulating. Bioerosion regulated systems use an immobilized enzyme on the surface of a polymer matrix to increase pH and degrade the polymer in the presence of a triggering agent. Bioresponsive systems control drug permeability through a bioresponsive membrane based on local biochemical concentrations. Self-regulating systems use competitive binding within a polymer encapsulated reservoir to activate drug release when triggered by a membrane permeable agent. Examples of insulin delivery are provided for the bioresponsive and self-regulating systems.
Video Lecture is available at https://www.youtube.com/watch?v=DXu_CLgB4q0
Introduction, terminology/definitions and rationale, advantages, disadvantages, selection of drug candidates. Approaches to design-controlled release formulations based on diffusion, dissolution and ion exchange principles. Physicochemical and
biological properties of drugs relevant to controlled release formulations.
This presentation discusses implantable drug delivery systems. It begins by defining implants as solid masses of purified drug intended for implantation via minor surgery or large bore needle to provide continuous drug release over long periods. Implants are well-suited for drugs like insulin, steroids, antibiotics, and analgesics. The presentation covers advantages like controlled delivery, improved compliance and stability. It also discusses types of implant systems including rate-programmed, activation-modulated, and feedback-regulated devices. Various mechanisms for controlling drug release like diffusion, hydration and enzymatic reactions are described. The conclusion emphasizes implants can provide targeted delivery without limitations of other administration methods.
Liposomes-Classification, methods of preparation and application Vijay Hemmadi
liposome preparation and application
A liposome is a tiny bubble (vesicle), made out of the same material as a cell membrane. Liposomes can be filled with drugs, and used to deliver drugs for cancer and other diseases. Membranes are usually made of phospholipids, which are molecules that have a head group and a tail group
This document discusses different types of rate controlled drug delivery systems. It begins by introducing controlled release drug delivery and distinguishing it from sustained release. It then classifies controlled release systems into three main categories: rate programmed, activation modulated, and feedback regulated systems. Within each category it describes several examples of systems, identifying how drug release is controlled in each case. Key factors that can affect controlled release are also listed. The document aims to provide an overview of controlled drug delivery technologies with classifications and examples.
This document discusses various approaches to developing implantable drug delivery systems, including controlled drug delivery via diffusion, activation processes, and feedback regulation. It describes systems that use polymer membranes, matrices, microreservoirs, and hybrid designs to control drug release rates. Activation methods include osmotic pressure, vapor pressure, magnetism, hydration, and hydrolysis. Feedback systems can be regulated by bioerosion and bioresponses to biochemical factors. The document provides examples of implantable systems and discusses how drug and system properties influence release kinetics.
This document discusses methods of formulating and evaluating buccal drug delivery systems. It describes the basic structure and designs of buccal dosage forms as being matrix or reservoir types. The key components are outlined as the drug substance, bioadhesive polymers, backing membrane, and permeation enhancers. Various formulation methods are provided for solid, semi-solid and liquid buccal dosage forms including tablets, patches, films, gels and sprays. Evaluation methods are also summarized such as weight variation, thickness, friability, hardness, and in-vitro swelling studies.
‘Targeted drug delivery system is a special form of drug delivery system where the medicament is selectively targeted or delivered only to its site of action or absorption and not to the non-target organs or tissues or cells.’
This document discusses three types of triggered drug delivery systems: bioerosion regulated, bioresponsive, and self-regulating. Bioerosion regulated systems use an immobilized enzyme on the surface of a polymer matrix to increase pH and degrade the polymer in the presence of a triggering agent. Bioresponsive systems control drug permeability through a bioresponsive membrane based on local biochemical concentrations. Self-regulating systems use competitive binding within a polymer encapsulated reservoir to activate drug release when triggered by a membrane permeable agent. Examples of insulin delivery are provided for the bioresponsive and self-regulating systems.
Video Lecture is available at https://www.youtube.com/watch?v=DXu_CLgB4q0
Introduction, terminology/definitions and rationale, advantages, disadvantages, selection of drug candidates. Approaches to design-controlled release formulations based on diffusion, dissolution and ion exchange principles. Physicochemical and
biological properties of drugs relevant to controlled release formulations.
This presentation discusses implantable drug delivery systems. It begins by defining implants as solid masses of purified drug intended for implantation via minor surgery or large bore needle to provide continuous drug release over long periods. Implants are well-suited for drugs like insulin, steroids, antibiotics, and analgesics. The presentation covers advantages like controlled delivery, improved compliance and stability. It also discusses types of implant systems including rate-programmed, activation-modulated, and feedback-regulated devices. Various mechanisms for controlling drug release like diffusion, hydration and enzymatic reactions are described. The conclusion emphasizes implants can provide targeted delivery without limitations of other administration methods.
Liposomes-Classification, methods of preparation and application Vijay Hemmadi
liposome preparation and application
A liposome is a tiny bubble (vesicle), made out of the same material as a cell membrane. Liposomes can be filled with drugs, and used to deliver drugs for cancer and other diseases. Membranes are usually made of phospholipids, which are molecules that have a head group and a tail group
This document discusses different types of rate controlled drug delivery systems. It begins by introducing controlled release drug delivery and distinguishing it from sustained release. It then classifies controlled release systems into three main categories: rate programmed, activation modulated, and feedback regulated systems. Within each category it describes several examples of systems, identifying how drug release is controlled in each case. Key factors that can affect controlled release are also listed. The document aims to provide an overview of controlled drug delivery technologies with classifications and examples.
This document discusses various approaches to developing implantable drug delivery systems, including controlled drug delivery via diffusion, activation processes, and feedback regulation. It describes systems that use polymer membranes, matrices, microreservoirs, and hybrid designs to control drug release rates. Activation methods include osmotic pressure, vapor pressure, magnetism, hydration, and hydrolysis. Feedback systems can be regulated by bioerosion and bioresponses to biochemical factors. The document provides examples of implantable systems and discusses how drug and system properties influence release kinetics.
This document discusses methods of formulating and evaluating buccal drug delivery systems. It describes the basic structure and designs of buccal dosage forms as being matrix or reservoir types. The key components are outlined as the drug substance, bioadhesive polymers, backing membrane, and permeation enhancers. Various formulation methods are provided for solid, semi-solid and liquid buccal dosage forms including tablets, patches, films, gels and sprays. Evaluation methods are also summarized such as weight variation, thickness, friability, hardness, and in-vitro swelling studies.
The document discusses controlled release drug delivery systems. It explains that controlled release systems aim to maintain drug levels within a therapeutic range by slowing drug release, reducing fluctuations in plasma drug concentrations. This improves therapeutic outcomes by minimizing side effects. The key types of controlled release systems discussed are diffusion-controlled, dissolution/coating-controlled, biodegradable, osmotic pumps, and prodrugs. Factors to consider in designing these systems include drug properties, route of administration, and pharmacological effects.
This document discusses mucoadhesive drug delivery systems (MDDS). It begins by defining MDDS as drug delivery systems that interact with mucus layers and increase drug residence time at absorption sites. It then discusses various types of MDDS (buccal, sublingual, etc.), advantages like prolonged drug effects, and challenges like irritation. The document also covers mucoadhesion theories, drug transport mechanisms, formulation considerations, and provides an example case study on salbutamol sulfate buccal patches.
The document provides information on nasopulmonary drug delivery systems including nasal drug delivery and pulmonary drug delivery. It discusses the anatomy and physiology of the nasal cavity and respiratory tract. It also describes various formulation approaches for nasal delivery such as nasal gels, drops, sprays and powders. The document further explains dry powder inhalers, metered dose inhalers and nebulizers as pulmonary drug delivery systems along with their advantages and disadvantages. It also discusses some marketed products for nasal sprays, dry powder inhalers and metered dose inhalers.
This document provides an overview of sustained and controlled drug delivery systems (SR and CRDDS). It defines SR and CRDDS and compares their drug release profiles. The advantages include improved bioavailability and compliance while disadvantages include dose dumping and adjustment difficulties. Drugs are selected based on their physicochemical, pharmacokinetic, and pharmacodynamic properties. SR and CRDDS are classified into continuous release, delayed transit-continuous release, and delayed release systems. They are evaluated for properties like drug release and stability. Applications include oral, ocular, transdermal, and colonic delivery. Marketed products of these systems in tablets, capsules, and transdermal forms are also mentioned.
Intrauterine & Intravaginal Drug Delivery SystemPRASHANT DEORE
This document discusses intrauterine and intravaginal drug delivery systems. It begins with an introduction and overview of anatomy and physiology of the female reproductive system. It then describes various types of intravaginal drug delivery systems including suppositories, bioadhesive semisolids, elastomeric rings, and solid polymeric carriers. Factors affecting vaginal drug absorption are also discussed. The document concludes by describing intrauterine drug delivery systems including non-hormonal and hormonal IUDs, and discussing advantages and disadvantages of both intravaginal and intrauterine systems.
This document discusses different types of controlled drug delivery systems. It classifies systems as rate preprogrammed, activation modulated, or feedback regulated. Rate preprogrammed systems are further broken down into polymer membrane permeation controlled systems, polymer matrix diffusion controlled systems, and microreservoir partition controlled systems. The key aspects and release kinetics of each system type are described through examples. Factors that influence drug release rates from these systems include membrane thickness, drug solubility, diffusivity, and partitioning coefficients.
This document provides an overview of gastric retention drug delivery systems (GRDDS). It discusses the need for and advantages of GRDDS. The key approaches covered for achieving gastric retention include floating drug delivery systems, mucoadhesive systems, swellable systems, and high density systems. The document reviews gastrointestinal physiology and factors affecting gastric emptying. It also evaluates different GRDDS approaches and provides examples of commercial gastroretentive formulations. In conclusion, the document states that GRDDS are preferable for delivering drugs that need to be released in the gastric region.
Osmotic drug delivery systems use osmotic pressure to provide controlled release of drugs over extended periods of time. They consist of a drug core surrounded by a semipermeable membrane with a delivery orifice. When exposed to fluids, osmotic pressure causes water to enter the system, dissolving the drug and pushing it out through the orifice at a controlled rate. The three main types are Rose-Nelson pumps, elementary osmotic pumps, and controlled porosity osmotic pumps. These systems offer advantages over traditional methods for conditions requiring prolonged, consistent drug levels.
Gastro retentive drug delivery system (GRDDS)Shweta Nehate
This document discusses gastro-retentive drug delivery systems (GRDDS), which aim to prolong the gastric residence time of drugs and target drug release in the upper gastrointestinal tract. It describes the physiology of the gastrointestinal tract and potential drug candidates for GRDDS. Various approaches for GRDDS are covered, including floating, high density, bioadhesive, swelling, and superporous hydrogel systems. Evaluation parameters, applications, marketed formulations, and conclusions about GRDDS are also summarized.
coacervation-phase separation technique in micro encapsulation Tejaswini Naredla
This document discusses the coacervation-phase separation technique for microencapsulation. It begins by introducing microencapsulation and listing several techniques. It then describes coacervation-phase separation in more detail, explaining that it involves separating a solution into three immiscible phases to deposit a coating material onto a core material. The document outlines the three main steps of this process: forming the three phases, depositing the coating material, and rigidizing the coating. It provides examples of techniques used in coacervation-phase separation like temperature change, incompatible polymer addition, and salt addition. In conclusion, it states this technique is used to sustain drug release and stabilize oxidation among other purposes.
This document discusses drug targeting and various drug delivery systems for targeted drug delivery. It describes how drug targeting aims to selectively deliver drugs to the site of action and not to non-target tissues. Various polymer-based particulate carriers for targeted drug delivery are then discussed, including liposomes, microspheres, nanoparticles, and polymeric micelles. The document provides details on the composition, preparation techniques and applications of these particulate carriers. Key advantages and challenges of different targeted drug delivery approaches are also summarized.
polymer in pharmacy and application of polymersRoshan Bodhe
This document discusses the use of polymers in pharmaceutical applications. It begins with an introduction that defines polymers as large molecules formed by linking repeating structural units through covalent bonds. The document then covers the classification, properties, characteristics, advantages, and applications of polymers. Some key points include that polymers can be classified based on their source, polymerization method, degradability, nature, and properties. They have advantages like localized and sustained drug delivery to improve patient compliance. Applications mentioned are in modified drug release systems, biomedical uses like tissue engineering, and industrial/agricultural packaging.
This document discusses mucoadhesive drug delivery systems, specifically focusing on their use for buccal drug delivery. It begins with an introduction to mucoadhesion and bioadhesion. It then outlines the various routes mucoadhesive systems can be delivered through, including buccal, oral, vaginal, rectal, nasal and ocular delivery. The document focuses on the advantages of oral mucoadhesive systems for prolonged drug residence in the oral cavity. It discusses considerations for buccal drug delivery formulations, including drug properties, excipients used and factors affecting transmucosal permeability.
Targeted drug delivery aims to maximize the concentration of drugs at their intended sites of action to improve efficacy and reduce side effects. It involves using drug carriers like liposomes, nanoparticles, and monoclonal antibodies to transport drugs. These carriers can actively or passively target drugs to specific organs, tissues, or cells. Ideal carriers for targeted delivery are non-toxic, stable, and can control drug release rates. Research focuses on developing various carrier types and targeting strategies like passive accumulation, ligand-receptor interactions, and saturation of the reticuloendothelial system. Targeted delivery holds promise for overcoming drug resistance and improving treatment of cancer, diabetes, and other diseases.
“Microparticles are defined as particulate dispersions or solid particles with a size in the range of 1-1000 μm.”
The drug is dissolved, entrapped, encapsulated or attached to a microparticle matrix.
Magnetic microspheres are small particles containing magnetite that can be guided to target tissues using external magnetic fields. They allow drugs to be delivered at lower doses directly to tissues while avoiding toxicity. Microspheres are prepared using methods like phase separation or solvent evaporation to encapsulate drugs and magnetite in carriers like albumin. Particle characteristics and drug release kinetics can be evaluated using techniques like dialysis, imaging, and microscopy. Magnetic microspheres show potential for targeted drug delivery but also have technical challenges for approval.
SUSTAINED RELEASE (SR) & CONTROL RELEASE.pptxRAHUL PAL
Sustained-release medications are usually labeled with “SR” at the end of their name. These medications prolong the medication's release from a tablet or capsule so that you'll get the medication's benefits over a longer period of time.
CR = controlled release, SR = sustained release, ER = extended release, IR = immediate release. *
This document discusses controlled drug delivery systems (CDDS). It defines CDDS as formulations that release medication over an extended period from a single dose to achieve prolonged therapeutic effects. The document outlines factors that influence CDDS design such as drug properties and pharmacokinetics. It also describes various release mechanisms, classification systems, and advantages like improved compliance and maintaining therapeutic drug levels. Potential disadvantages include dumping and patient variability affecting release rates. The document concludes that CDDS can improve drug efficacy, safety, and dosing convenience compared to conventional formulations.
This document discusses various novel drug delivery systems including oral controlled release systems, parenteral controlled release systems, and targeted drug delivery systems using nanoparticles. It provides details on different types of modified release dosage forms including extended release and delayed release. It also discusses rationales for controlled drug delivery systems and various approaches to control drug release including sustained action, localized action, and targeted action. Specific drug delivery systems covered include oral, parenteral, site-specific targeting, receptor targeting, delayed release, sustained release, gastroretentive, and colon-specific delivery systems. Design and formulation of these various drug delivery systems is also summarized.
The document discusses controlled release drug delivery systems. It explains that controlled release systems aim to maintain drug levels within a therapeutic range by slowing drug release, reducing fluctuations in plasma drug concentrations. This improves therapeutic outcomes by minimizing side effects. The key types of controlled release systems discussed are diffusion-controlled, dissolution/coating-controlled, biodegradable, osmotic pumps, and prodrugs. Factors to consider in designing these systems include drug properties, route of administration, and pharmacological effects.
This document discusses mucoadhesive drug delivery systems (MDDS). It begins by defining MDDS as drug delivery systems that interact with mucus layers and increase drug residence time at absorption sites. It then discusses various types of MDDS (buccal, sublingual, etc.), advantages like prolonged drug effects, and challenges like irritation. The document also covers mucoadhesion theories, drug transport mechanisms, formulation considerations, and provides an example case study on salbutamol sulfate buccal patches.
The document provides information on nasopulmonary drug delivery systems including nasal drug delivery and pulmonary drug delivery. It discusses the anatomy and physiology of the nasal cavity and respiratory tract. It also describes various formulation approaches for nasal delivery such as nasal gels, drops, sprays and powders. The document further explains dry powder inhalers, metered dose inhalers and nebulizers as pulmonary drug delivery systems along with their advantages and disadvantages. It also discusses some marketed products for nasal sprays, dry powder inhalers and metered dose inhalers.
This document provides an overview of sustained and controlled drug delivery systems (SR and CRDDS). It defines SR and CRDDS and compares their drug release profiles. The advantages include improved bioavailability and compliance while disadvantages include dose dumping and adjustment difficulties. Drugs are selected based on their physicochemical, pharmacokinetic, and pharmacodynamic properties. SR and CRDDS are classified into continuous release, delayed transit-continuous release, and delayed release systems. They are evaluated for properties like drug release and stability. Applications include oral, ocular, transdermal, and colonic delivery. Marketed products of these systems in tablets, capsules, and transdermal forms are also mentioned.
Intrauterine & Intravaginal Drug Delivery SystemPRASHANT DEORE
This document discusses intrauterine and intravaginal drug delivery systems. It begins with an introduction and overview of anatomy and physiology of the female reproductive system. It then describes various types of intravaginal drug delivery systems including suppositories, bioadhesive semisolids, elastomeric rings, and solid polymeric carriers. Factors affecting vaginal drug absorption are also discussed. The document concludes by describing intrauterine drug delivery systems including non-hormonal and hormonal IUDs, and discussing advantages and disadvantages of both intravaginal and intrauterine systems.
This document discusses different types of controlled drug delivery systems. It classifies systems as rate preprogrammed, activation modulated, or feedback regulated. Rate preprogrammed systems are further broken down into polymer membrane permeation controlled systems, polymer matrix diffusion controlled systems, and microreservoir partition controlled systems. The key aspects and release kinetics of each system type are described through examples. Factors that influence drug release rates from these systems include membrane thickness, drug solubility, diffusivity, and partitioning coefficients.
This document provides an overview of gastric retention drug delivery systems (GRDDS). It discusses the need for and advantages of GRDDS. The key approaches covered for achieving gastric retention include floating drug delivery systems, mucoadhesive systems, swellable systems, and high density systems. The document reviews gastrointestinal physiology and factors affecting gastric emptying. It also evaluates different GRDDS approaches and provides examples of commercial gastroretentive formulations. In conclusion, the document states that GRDDS are preferable for delivering drugs that need to be released in the gastric region.
Osmotic drug delivery systems use osmotic pressure to provide controlled release of drugs over extended periods of time. They consist of a drug core surrounded by a semipermeable membrane with a delivery orifice. When exposed to fluids, osmotic pressure causes water to enter the system, dissolving the drug and pushing it out through the orifice at a controlled rate. The three main types are Rose-Nelson pumps, elementary osmotic pumps, and controlled porosity osmotic pumps. These systems offer advantages over traditional methods for conditions requiring prolonged, consistent drug levels.
Gastro retentive drug delivery system (GRDDS)Shweta Nehate
This document discusses gastro-retentive drug delivery systems (GRDDS), which aim to prolong the gastric residence time of drugs and target drug release in the upper gastrointestinal tract. It describes the physiology of the gastrointestinal tract and potential drug candidates for GRDDS. Various approaches for GRDDS are covered, including floating, high density, bioadhesive, swelling, and superporous hydrogel systems. Evaluation parameters, applications, marketed formulations, and conclusions about GRDDS are also summarized.
coacervation-phase separation technique in micro encapsulation Tejaswini Naredla
This document discusses the coacervation-phase separation technique for microencapsulation. It begins by introducing microencapsulation and listing several techniques. It then describes coacervation-phase separation in more detail, explaining that it involves separating a solution into three immiscible phases to deposit a coating material onto a core material. The document outlines the three main steps of this process: forming the three phases, depositing the coating material, and rigidizing the coating. It provides examples of techniques used in coacervation-phase separation like temperature change, incompatible polymer addition, and salt addition. In conclusion, it states this technique is used to sustain drug release and stabilize oxidation among other purposes.
This document discusses drug targeting and various drug delivery systems for targeted drug delivery. It describes how drug targeting aims to selectively deliver drugs to the site of action and not to non-target tissues. Various polymer-based particulate carriers for targeted drug delivery are then discussed, including liposomes, microspheres, nanoparticles, and polymeric micelles. The document provides details on the composition, preparation techniques and applications of these particulate carriers. Key advantages and challenges of different targeted drug delivery approaches are also summarized.
polymer in pharmacy and application of polymersRoshan Bodhe
This document discusses the use of polymers in pharmaceutical applications. It begins with an introduction that defines polymers as large molecules formed by linking repeating structural units through covalent bonds. The document then covers the classification, properties, characteristics, advantages, and applications of polymers. Some key points include that polymers can be classified based on their source, polymerization method, degradability, nature, and properties. They have advantages like localized and sustained drug delivery to improve patient compliance. Applications mentioned are in modified drug release systems, biomedical uses like tissue engineering, and industrial/agricultural packaging.
This document discusses mucoadhesive drug delivery systems, specifically focusing on their use for buccal drug delivery. It begins with an introduction to mucoadhesion and bioadhesion. It then outlines the various routes mucoadhesive systems can be delivered through, including buccal, oral, vaginal, rectal, nasal and ocular delivery. The document focuses on the advantages of oral mucoadhesive systems for prolonged drug residence in the oral cavity. It discusses considerations for buccal drug delivery formulations, including drug properties, excipients used and factors affecting transmucosal permeability.
Targeted drug delivery aims to maximize the concentration of drugs at their intended sites of action to improve efficacy and reduce side effects. It involves using drug carriers like liposomes, nanoparticles, and monoclonal antibodies to transport drugs. These carriers can actively or passively target drugs to specific organs, tissues, or cells. Ideal carriers for targeted delivery are non-toxic, stable, and can control drug release rates. Research focuses on developing various carrier types and targeting strategies like passive accumulation, ligand-receptor interactions, and saturation of the reticuloendothelial system. Targeted delivery holds promise for overcoming drug resistance and improving treatment of cancer, diabetes, and other diseases.
“Microparticles are defined as particulate dispersions or solid particles with a size in the range of 1-1000 μm.”
The drug is dissolved, entrapped, encapsulated or attached to a microparticle matrix.
Magnetic microspheres are small particles containing magnetite that can be guided to target tissues using external magnetic fields. They allow drugs to be delivered at lower doses directly to tissues while avoiding toxicity. Microspheres are prepared using methods like phase separation or solvent evaporation to encapsulate drugs and magnetite in carriers like albumin. Particle characteristics and drug release kinetics can be evaluated using techniques like dialysis, imaging, and microscopy. Magnetic microspheres show potential for targeted drug delivery but also have technical challenges for approval.
SUSTAINED RELEASE (SR) & CONTROL RELEASE.pptxRAHUL PAL
Sustained-release medications are usually labeled with “SR” at the end of their name. These medications prolong the medication's release from a tablet or capsule so that you'll get the medication's benefits over a longer period of time.
CR = controlled release, SR = sustained release, ER = extended release, IR = immediate release. *
This document discusses controlled drug delivery systems (CDDS). It defines CDDS as formulations that release medication over an extended period from a single dose to achieve prolonged therapeutic effects. The document outlines factors that influence CDDS design such as drug properties and pharmacokinetics. It also describes various release mechanisms, classification systems, and advantages like improved compliance and maintaining therapeutic drug levels. Potential disadvantages include dumping and patient variability affecting release rates. The document concludes that CDDS can improve drug efficacy, safety, and dosing convenience compared to conventional formulations.
This document discusses various novel drug delivery systems including oral controlled release systems, parenteral controlled release systems, and targeted drug delivery systems using nanoparticles. It provides details on different types of modified release dosage forms including extended release and delayed release. It also discusses rationales for controlled drug delivery systems and various approaches to control drug release including sustained action, localized action, and targeted action. Specific drug delivery systems covered include oral, parenteral, site-specific targeting, receptor targeting, delayed release, sustained release, gastroretentive, and colon-specific delivery systems. Design and formulation of these various drug delivery systems is also summarized.
Implants- B.Pharm SEM 7- Novel Drug Delivery Systemvedanshu malviya
Implantable drug delivery device classification is not a straightforward task as there are a number of complex implants that will fall into hybrid categories. Nevertheless, implantable drug delivery devices can be broadly classified in two main groups: passive implants and active implants. The first group includes two main types of implants: biodegradable and non-biodegradable implants. On the other hand, active systems rely on energy dependent methods that provide the driving force to control drug release. The second group includes devices such as osmotic pressure gradients and electromechanical drives.
Controlled drug delivery systems were first developed in the 1940s-1950s to provide sustained drug release. Over the past 30 years, controlled drug delivery systems have gained more attention due to their advantages like maintaining therapeutic drug levels and reducing dosing frequency. Controlled release drug delivery systems can be classified based on their release mechanisms and include dissolution-controlled, diffusion-controlled, and osmotic pressure-controlled systems. Factors like drug properties, dosage form properties, and biological factors influence controlled drug delivery systems.
This document discusses implantable drug delivery systems. It begins by outlining the need for such systems to improve drug delivery and patient compliance. It then classifies implantable systems as passive or active. Passive systems rely on diffusion for drug release, while active systems use pumps or other mechanisms. The document reviews various polymer-based implant designs, materials, and drug release mechanisms. It provides examples of commercial implantable systems for applications like contraception, cancer treatment, and pain management. Overall challenges with implantable drugs are biocompatibility and controlling drug release over long periods.
This document discusses various drug delivery systems. It begins by describing conventional delivery systems like pills and injections. It then defines controlled drug delivery as combining a drug with a carrier to release it in a predetermined manner. New techniques allow controlling the rate, targeting the delivery site, and responding to environmental changes. The need is for more effective therapies while avoiding under- and overdosing. Various delivery mechanisms, materials, carriers, and examples are provided. The document also discusses transdermal, pulmonary, and ocular delivery systems. It concludes by mentioning floating oral delivery systems that increase gastric emptying time and target the colon.
This document discusses controlled drug delivery systems. It begins by defining controlled drug delivery systems and their goal of releasing therapeutic doses of a drug in the desired location and time period. It then discusses various types of modified release dosage forms like sustained release, extended release, and controlled release. The document covers advantages and disadvantages of these systems as well as factors influencing their design and performance. It provides examples of commercial modified release products and discusses approaches to designing controlled release formulations.
This document discusses trans mucosal drug delivery systems. It begins by comparing traditional drug delivery routes like oral and parenteral and their limitations. It then introduces trans mucosal delivery as an alternative that avoids first pass metabolism and provides controlled release. The document discusses the anatomy and characteristics of different mucosal sites. It also examines factors that influence trans mucosal delivery such as drug properties, biological factors, and formulation techniques. Finally, it reviews various trans mucosal delivery devices, methods for optimizing formulations, and quality control testing.
Formulation and evaluation of sustained release tablets of ambroxol hcl using...Venkatesh Pillala
This document provides an introduction and literature review for formulating and evaluating sustained release tablets of Ambroxol HCl using natural polymers. It discusses sustained release dosage forms, factors affecting oral sustained release dosage forms, parameters for drug selection, formulation methods, and mechanisms of drug release from matrix tablets. The literature review covers previous studies on formulating sustained release dosage forms for other drugs using natural polymers. The objective is stated as preparing and evaluating sustained release tablets of Ambroxol HCl to improve its oral bioavailability, reduce dosing frequency, and optimize polymer concentrations.
This document discusses sustained release dosage forms. It begins by introducing the goals of sustained release therapy, which are to achieve steady blood levels of a drug for an extended period of time to maximize drug availability and control effects. It then covers sustained release classifications and advantages over conventional therapy. The key approaches to sustained release are drug modifications or dosage form modifications. Drug modifications involve complexing, adsorbates or prodrugs, while dosage form modifications use embedded matrices, barriers or multilayered tablets to control drug release. Product evaluation involves in vitro dissolution testing and in vivo studies to validate designs.
This document discusses solid oral modified release dosage forms and drug delivery systems. It begins by providing background on the US prescription drug market and extended release products. It then discusses the rationale for extended release pharmaceuticals and terminology used. The document outlines various technologies for achieving extended release including coated beads/granules, multi-tablet systems, microencapsulation, embedding in eroding/hydrophilic matrices, inert plastic matrices, and more. It covers USP requirements, in vitro-in vivo correlations, and clinical considerations for these modified release products.
This document discusses polymer membrane permeation controlled drug delivery systems. It defines controlled release as delivering drugs at predetermined rates over long periods from a single dose. Controlled release implies predictable and reproducible drug release kinetics. A key example is a system where a drug reservoir is covered by a rate-controlling polymeric membrane. The membrane thickness and drug properties determine the release rate. Applications include the Norplant implant and Ocusert ocular insert.
Application of polymers in oral sustained drug delivery systemprashant bhamare
This document discusses polymers used in oral sustained drug delivery systems. It defines polymers and sustained drug delivery systems. Some key advantages of sustained release systems are reduced dosing frequency and more consistent drug levels. Matrix and reservoir systems are two formulation approaches that use insoluble or erodible polymers to control drug dissolution or diffusion rates. Examples of polymers commonly used include cellulose derivatives, waxes, and acrylic acid copolymers. Matrix tablets containing carbopol, HPMC or EC can provide extended release of drugs like zidovudine or diclofenac sodium. Sustained release drug delivery systems aim to prolong the therapeutic effects of drugs over time.
Sustained and Controlled Drug Delivery System.pptxHarshadaa bafna
This document provides information about sustained and controlled drug delivery systems. It begins with definitions of sustained release and controlled release, and discusses the advantages of maintaining consistent drug levels over time. It then covers topics like steady state concepts, diffusion mechanisms, dissolution models and polymer characterization as they relate to sustained and controlled release drug delivery. Evaluation methods for sustained release and controlled release tablets are also mentioned.
Polymers in controlled release Drug Delivery System.pptxDeepMaity3
Polymers play a pivotal role in controlled release drug delivery systems, revolutionizing the way medications are administered and absorbed in the human body. These systems are designed to release drugs at a controlled rate, ensuring optimal therapeutic effects while minimizing side effects. One of the key advantages of using polymers is their ability to modulate drug release rates, enhancing patient compliance and overall treatment outcomes.
In controlled release drug delivery, polymers act as carriers or matrices for the active pharmaceutical ingredients (APIs). These polymers can be natural or synthetic, each offering unique properties. Natural polymers like cellulose derivatives and proteins are biocompatible and biodegradable, making them safe for use in the human body. On the other hand, synthetic polymers such as poly(lactic-co-glycolic acid) (PLGA) and polyethylene glycol (PEG) provide precise control over drug release due to their tunable properties.
The formulation process involves incorporating the drug into the polymer matrix or attaching it to the polymer chains. Depending on the desired release profile, polymers can be engineered to release drugs in various ways: diffusion-controlled release, where the drug diffuses through the polymer matrix; erosion-controlled release, where the polymer degrades over time, releasing the drug; and chemically controlled release, where the drug is bound to the polymer via chemical bonds and is released as these bonds break.
Moreover, polymers enable targeted drug delivery to specific sites in the body. By modifying the surface properties of polymer particles or incorporating targeting ligands, drugs can be delivered precisely to the diseased tissues, increasing drug efficacy and reducing systemic side effects. This targeted approach is particularly beneficial in cancer therapy, where localized delivery minimizes damage to healthy cells.
Additionally, polymers used in controlled release systems protect drugs from degradation, ensuring their stability during storage and transportation. This extends the shelf life of pharmaceutical products and maintains their efficacy until they reach the end-users.
In summary, polymers are the cornerstone of controlled release drug delivery systems, offering versatility, precision, and safety. Through their unique properties and the ability to tailor their behavior, polymers have paved the way for more effective and patient-friendly drug therapies, ultimately improving the quality of healthcare worldwide.
Noscapine based oral colon SpecificNanoparticles by Kuldipsinh Thakorkulu2929
This document discusses the design, development and evaluation of oral colon-specific nanoparticles of noscapiene for treating cancer. It begins with an introduction to the drug noscapiene and outlines the need, objectives and plan for the research. It then reviews relevant literature and patents. The materials and methodology, results and discussion are presented. It concludes with a summary and references. The overall aim is to develop a targeted colon-specific drug delivery system using noscapiene-loaded nanoparticles to treat colon cancer and related diseases while avoiding premature drug release in the stomach and small intestine.
The document discusses implants and inserts as drug delivery systems. It defines implants as single unit drug delivery systems designed to deliver a drug over a prolonged period of time. Implants can be biodegradable or non-biodegradable and come in various shapes, sizes, and drug release mechanisms. The document then discusses the advantages and disadvantages of implants, ideal characteristics, mechanisms of drug release including diffusion controlled and activated controlled systems, approaches to development, types of devices based on route of administration, and evaluation of implants.
Formulation & evaluation of Sustained release matrix tabletPrathamesh Patil
This document summarizes the formulation and evaluation of sustained release matrix tablets containing the drug levofloxacin. Matrix tablets were prepared using natural polymers like guar gum, karaya gum, and xanthan gum to achieve sustained release over 12 hours. Tablets were prepared by direct compression and evaluated for properties like weight variation, hardness, thickness, friability, and dissolution. Formulation F7, containing the polymers in a 40 mg ratio, provided 12 hours of drug release and was considered the optimized sustained release formulation.
Walmart Business+ and Spark Good for Nonprofits.pdfTechSoup
"Learn about all the ways Walmart supports nonprofit organizations.
You will hear from Liz Willett, the Head of Nonprofits, and hear about what Walmart is doing to help nonprofits, including Walmart Business and Spark Good. Walmart Business+ is a new offer for nonprofits that offers discounts and also streamlines nonprofits order and expense tracking, saving time and money.
The webinar may also give some examples on how nonprofits can best leverage Walmart Business+.
The event will cover the following::
Walmart Business + (https://business.walmart.com/plus) is a new shopping experience for nonprofits, schools, and local business customers that connects an exclusive online shopping experience to stores. Benefits include free delivery and shipping, a 'Spend Analytics” feature, special discounts, deals and tax-exempt shopping.
Special TechSoup offer for a free 180 days membership, and up to $150 in discounts on eligible orders.
Spark Good (walmart.com/sparkgood) is a charitable platform that enables nonprofits to receive donations directly from customers and associates.
Answers about how you can do more with Walmart!"
This presentation includes basic of PCOS their pathology and treatment and also Ayurveda correlation of PCOS and Ayurvedic line of treatment mentioned in classics.
How to Manage Your Lost Opportunities in Odoo 17 CRMCeline George
Odoo 17 CRM allows us to track why we lose sales opportunities with "Lost Reasons." This helps analyze our sales process and identify areas for improvement. Here's how to configure lost reasons in Odoo 17 CRM
Strategies for Effective Upskilling is a presentation by Chinwendu Peace in a Your Skill Boost Masterclass organisation by the Excellence Foundation for South Sudan on 08th and 09th June 2024 from 1 PM to 3 PM on each day.
বাংলাদেশের অর্থনৈতিক সমীক্ষা ২০২৪ [Bangladesh Economic Review 2024 Bangla.pdf] কম্পিউটার , ট্যাব ও স্মার্ট ফোন ভার্সন সহ সম্পূর্ণ বাংলা ই-বুক বা pdf বই " সুচিপত্র ...বুকমার্ক মেনু 🔖 ও হাইপার লিংক মেনু 📝👆 যুক্ত ..
আমাদের সবার জন্য খুব খুব গুরুত্বপূর্ণ একটি বই ..বিসিএস, ব্যাংক, ইউনিভার্সিটি ভর্তি ও যে কোন প্রতিযোগিতা মূলক পরীক্ষার জন্য এর খুব ইম্পরট্যান্ট একটি বিষয় ...তাছাড়া বাংলাদেশের সাম্প্রতিক যে কোন ডাটা বা তথ্য এই বইতে পাবেন ...
তাই একজন নাগরিক হিসাবে এই তথ্য গুলো আপনার জানা প্রয়োজন ...।
বিসিএস ও ব্যাংক এর লিখিত পরীক্ষা ...+এছাড়া মাধ্যমিক ও উচ্চমাধ্যমিকের স্টুডেন্টদের জন্য অনেক কাজে আসবে ...
LAND USE LAND COVER AND NDVI OF MIRZAPUR DISTRICT, UPRAHUL
This Dissertation explores the particular circumstances of Mirzapur, a region located in the
core of India. Mirzapur, with its varied terrains and abundant biodiversity, offers an optimal
environment for investigating the changes in vegetation cover dynamics. Our study utilizes
advanced technologies such as GIS (Geographic Information Systems) and Remote sensing to
analyze the transformations that have taken place over the course of a decade.
The complex relationship between human activities and the environment has been the focus
of extensive research and worry. As the global community grapples with swift urbanization,
population expansion, and economic progress, the effects on natural ecosystems are becoming
more evident. A crucial element of this impact is the alteration of vegetation cover, which plays a
significant role in maintaining the ecological equilibrium of our planet.Land serves as the foundation for all human activities and provides the necessary materials for
these activities. As the most crucial natural resource, its utilization by humans results in different
'Land uses,' which are determined by both human activities and the physical characteristics of the
land.
The utilization of land is impacted by human needs and environmental factors. In countries
like India, rapid population growth and the emphasis on extensive resource exploitation can lead
to significant land degradation, adversely affecting the region's land cover.
Therefore, human intervention has significantly influenced land use patterns over many
centuries, evolving its structure over time and space. In the present era, these changes have
accelerated due to factors such as agriculture and urbanization. Information regarding land use and
cover is essential for various planning and management tasks related to the Earth's surface,
providing crucial environmental data for scientific, resource management, policy purposes, and
diverse human activities.
Accurate understanding of land use and cover is imperative for the development planning
of any area. Consequently, a wide range of professionals, including earth system scientists, land
and water managers, and urban planners, are interested in obtaining data on land use and cover
changes, conversion trends, and other related patterns. The spatial dimensions of land use and
cover support policymakers and scientists in making well-informed decisions, as alterations in
these patterns indicate shifts in economic and social conditions. Monitoring such changes with the
help of Advanced technologies like Remote Sensing and Geographic Information Systems is
crucial for coordinated efforts across different administrative levels. Advanced technologies like
Remote Sensing and Geographic Information Systems
9
Changes in vegetation cover refer to variations in the distribution, composition, and overall
structure of plant communities across different temporal and spatial scales. These changes can
occur natural.
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...Dr. Vinod Kumar Kanvaria
Exploiting Artificial Intelligence for Empowering Researchers and Faculty,
International FDP on Fundamentals of Research in Social Sciences
at Integral University, Lucknow, 06.06.2024
By Dr. Vinod Kumar Kanvaria
How to Make a Field Mandatory in Odoo 17Celine George
In Odoo, making a field required can be done through both Python code and XML views. When you set the required attribute to True in Python code, it makes the field required across all views where it's used. Conversely, when you set the required attribute in XML views, it makes the field required only in the context of that particular view.
Main Java[All of the Base Concepts}.docxadhitya5119
This is part 1 of my Java Learning Journey. This Contains Custom methods, classes, constructors, packages, multithreading , try- catch block, finally block and more.
How to Fix the Import Error in the Odoo 17Celine George
An import error occurs when a program fails to import a module or library, disrupting its execution. In languages like Python, this issue arises when the specified module cannot be found or accessed, hindering the program's functionality. Resolving import errors is crucial for maintaining smooth software operation and uninterrupted development processes.
1. Controlled Release Drug Delivery
Systems(CRDDS)
By Miyanda Petty. M
M.Pharmaceutics
CT Institute of Pharmacetical Sciences
2. Contents
• Definition
• Rationale
• Advantages
• Factors influencing design of CRDDS
• Characteristics making drug unsuitable for
CRDDS formulation
• Classification
3. Definition
• Refers to the use of a delivery device with the
objective of releasing drug at a predetermined
rate or at specific times or with specific
release profiles
• They provide a release profile independent of
the external environment and predominantly
controlled by the design of the system
4. • Controlled release systems are multiple dose
systems designed to achieve a steady state of
concentration.
5. Rationale of controlled drug delivery
• The basic idea behind controlled drug delivery concept is to
alter the pharmacokinetics and pharmacodynamics of
bioactives either by modifying the molecular structure ,and
• or physiological parameters by an alternative route of
administration or by using novel drug delivery systems .
• The primary objective of CRRDS is to ensure safety and
enhance efficacy of drug with improved patience compliance
6. Advantages of CRDDS
• Controlled delivery of active agent at predetermined
rate
• Maintenance of optimal and effective drug level for
prolonged periods
• Reduction of untoward effects like git irritation
• Increased patient compliance
7. • Reduction in dosing frequency
• Drug delivery in the vicinity of site of action
• More efficient utilization of active ingredient
• Avoidance of night time dosing
8. Factors Influencing Design of Controlled Release Dosage Forms
Variables to be considered for design of controlled release
products:
• Drug related (physicochemial properties of he drug)
Aqueous solubility ,partition coefficient ,stability ,charge
,molecular size and protein binding .
• Biological factors
Absorption,distribution,elimination,duration of action,magin of
safety,side effects
9. • Physiological factors
Gastrointestinal blood flow, variability in GI
emptying and motility. prolonged drug
absorption
• Pharmacokinetic factors
Dose dumping, first pass metabolism ,variability
of urinary PH effect on drug elimination
10. • Acute or chronic therapy-expected length of therapy to
achieve cure or control of disease
• Target sites -untoward effects can be minimized by
localization of drug to desired area by use of novel carriers
• patient factors
Patient condition whether ambulatory or bed riddden, obese
or gaunt, age (young/old )
11. • Disease state
Hepatic failure-oral drug delivery sould be
avoided.Renal failure ,heart failure(evaluate
bllod flow) etc
12. Characteristics of Drug Molecule Rendering it
Unsuitable for Controlled Release Dosing
• Too short /long elimination half life
• Narrow therapeutic index
• Poor absorption
• Large doses
• Low aqueous solubility
• Extensive first pass metabolism
13. Classification of Controlled Release
Systems
Type of system Rate control mechanism
Diffusion controlled
reservoir systems
Monolithic systems
Diffusion through membrane (both)
Water penetration controlled
Osmotic systems
Swelling systems
Osmotic transport of water through semi
permeable membrane
Water penetration into glassy polymer
Chemically controlled
Monolithic systems
Pendent systems
Ion exchange resins
Either by surface erosion or combination
with bulk erosion
Combination of hydrolysis of pendent
group and diffusion from bulk polymer
Exchange of acidic or basic drugs with the
ions present on resins
14. Type of system Rate control mechanism
Regulated system
Magnetic ,ultrasound
Chemical
External application of magnetic field of
ultrasound to device.
Use of competitive desorption or enzyme
substrate reactions. Rate control is built
into device.
15. Advantages and Disadvantages of Matrix and Reservoir systems
Matrix system Reservoir system
Very easy to fabricate in a wide range of
size and shapes.
Achievement of zero order release is easy
Suitable for both non-gradable and
degradable systems.
Very easy to fabricate in wide range of
sizes and shapes
No danger of dose dumping in case of
rupture .
Drug inactivation by contact with the
polymeric matrix can be avoided
Achievement of ‘zero order ‘ release is
difficult not all drugs can be blended with
a given polymeric matrix
Rupture can result in dangerous dose
dumping
Water soluble drugs have a tendency to
’burst’ from the system
Degradable reservoir systems may be
difficult to design